Italian Medicines Agency approves reimbursed access to Bylvay (odevixibat) for patients with all PFIC types

6 September 2022 - Positive Agenzia Italiana del Farmaco (AIFA) decision provides reimbursed access to the first medicine available for the ...

Read more →

Orchard Therapeutics announces reimbursement agreement making Libmeldy available for all eligible MLD patients in Italy

11 April 2022 - Orchard Therapeutics today announced it has reached another historic reimbursement agreement with the Italian Medicines Agency, also ...

Read more →

The evolution of the Italian National Health Service

22 October 2021 - 40 years ago, Italy saw the birth of a national, universal health care system (Servizio Sanitario Nazionale ...

Read more →

Theratechnologies announces reimbursement agreement in Italy for Trogarzo for eligible patients with multi-drug resistant HIV-1

26 October 2021 - Theratechnologies  is pleased to announce that it has reached an agreement with the Italian Medicines Agency, AIFA, ...

Read more →

Drug prices and value of oncology drugs in Italy

13 September 2021 - The main objective of this study was to evaluate the potential role of efficacy data and other ...

Read more →

Vertex announces new portfolio reimbursement agreement in Italy including Kaftrio, Symkevi and additional indications of Orkambi and Kalydeco for eligible patients with cystic fibrosis

25 June 2021 - Reimbursement agreement also includes certain future indication extensions across all Vertex cystic fibrosis medicines. ...

Read more →

Italy ponders suing Pfizer for delays in coronavirus vaccine

21 January 2021 - Italy's coronavirus commissioner is pressing ahead with plans to take legal action against Pfizer after the ...

Read more →

Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actions

10 September 2020 - The purpose of this study was to evaluate the current state of health economic evaluations submitted by ...

Read more →

Italy becomes first country to require pharma to disclose public funding for R&D costs

6 August 2020 - Amid growing clamour for more transparency from the pharmaceutical industry, Italy has become the first country ...

Read more →

Akcea announces approval for reimbursement of Tegsedi (inotersen) in Italy for treatment of hereditary transthyretin amyloidosis with polyneuropathy

8 June 2020 - Tegsedi is the first antisense oligonucleotide medicine available to hATTR patients with polyneuropathy in Italy for at-home ...

Read more →

Using GRADE methodology to assess innovation of new medicinal products in Italy

25 November 2019 - In April 2017 the Italian Medicine Agency developed new criteria to grant any new medicinal product with ...

Read more →

Clovis Oncology announces reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Italy

13 November 2019 - Rucaparib now reimbursed in several countries in Europe with additional countries to follow in 2020. ...

Read more →

Why the Italian health minister is pushing for global transparency on drug pricing

12 March 2019 - Last month, the Italian government asked the World Health Assembly to adopt a resolution to require drug ...

Read more →

Italy serves cautionary lesson for new Trump drug plan

17 April 2018 - The Trump administration is pushing drug plans that tie costs to performance as a way to lower ...

Read more →

Italy continues protest against EMA move to Amsterdam

23 February 2018 - The Italian protest against the relocation of the EMA from London to Amsterdam continued during a ...

Read more →